Pharmacodynamics of the new H1-antagonist 3-amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride in volunteers.

MLA

Adamus, W. S., et al. “Pharmacodynamics of the New H1-Antagonist 3-Amino-9,13b-Dihydro-1H-Dibenz[c,f]Imidazo[1,5-a]Azepine Hydrochloride in Volunteers.” Arzneimittel-Forschung, vol. 37, no. 5, May 1987, pp. 569–72. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2887173&authtype=sso&custid=ns315887.

APA

Adamus, W. S., Oldigs-Kerber, J., & Lohmann, H. (1987). Pharmacodynamics of the new H1-antagonist 3-amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride in volunteers. Arzneimittel-Forschung, 37(5), 569–572.

Chicago

Adamus, W S, J Oldigs-Kerber, and H Lohmann. 1987. “Pharmacodynamics of the New H1-Antagonist 3-Amino-9,13b-Dihydro-1H-Dibenz[c,f]Imidazo[1,5-a]Azepine Hydrochloride in Volunteers.” Arzneimittel-Forschung 37 (5): 569–72. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2887173&authtype=sso&custid=ns315887.